abortions. And if this were true then women with high hormone concentrations would have a lower fecundity than other women (taking more time to become recognisably pregnant because of unrecognised spontaneous abortions). This thesis seems to be false, however, because DZ twins (who themselves tend to be conceived when gonadotrophin concentrations are.high) take less, not more, time to conceive than singletons.'7 18
The mean (± SEM) serum concentration of 25-hydroxy vitamin D was significantly (p<001) lower in patients receiving haemodialysis (36-0± 3-8 nmol/l (14-4±1-5 ng/ml)) than controls (53-8±3-6 nmol/l (21-5±1-4 ng/ ml)). The mean concentrations in patients with advanced renal failure not requiring haemodialysis (43 5±5 3 nmol/l (17-4±2-1 ng/ml)) and in patients with mildtomoderaterenalfailure(47-6±3 6nmol/1(190±1 .4ng/ ml)) did not differ from that in controls. The mean serum concentration of 24,25-dihydroxy vitamin D (figure) and the mean ratio of serum concentrations of 24,25-dihydroxy vitamin D to those of 25-hydroxy vitamin D were significantly lower (p<001) in the patients receiving haemodialysis (1-18±0-40 nmol/l (0-5±0-16 ng/ml) and 0030±0:003 respectively), the patients with advanced renal failure not requiring haemodialysis (1-88± 0-25 nmol/l (0 75±0 1 ng/ml) and 0-042±0 004 respectively), and the patients with mild to moderate renal failure (2-70±0-22 nmol/l (1 1 ±0 09 ng/ ml) and 0-058±0 003) compared with the controls (4-78±0 30 nmol/l (1-9±0-12 ng/ml) and 0-092±0-004). The ratios of the two metabolites were directly correlated (r=0-72, p<0005) with the creatinine clearances when data from all patients were analysed. 
Comment
Our results show that serum concentrations of 24,25-dihydroxy vitamin D are depressed in mild to moderate chronic renal failure and are low or undetectable in patients receiving dialysis. Reduced production of 1 a, 25-dihydroxy vitamin D by the diseased kidney is generally believed to be important in the pathogenesis of renal osteodystrophy, and the serum concentration of this metabolite is extremely low in advanced renal failure; the concentration is normal or increased, however, in patients with early to moderate renal failure, in whom hypocalcaemia, secondary hyperparathyroidism, and defective bone mineralisation are often present. 4 Achieving good control of blood glucose concentration in diabetes is important1 2 but may be complicated by patients' reluctance to accept multiple injections of insulin and difficulty in synchronising carbohydrate and insulin absorption. Jet injection is reportedly less painful3 and may provide faster absorption of insulin than standard syringe and needle.3 4 Patients, methods, and results Thirteen insulin-dependent inpatient diabetics aged 17-18 were studied. Ten were receiving short-acting and intermediate-acting insulins twice daily and three once daily. All patients were stable for 48 hours before the study and were allocated alternately to group 1 (insulin injected by syringe and needle on day 1 and by injector gun on day 2) or group 2 (injector gun on day 1 and syringe and needle on day 2). Jet injections were given using the Med-E-Jet device (Med-E-Jet Limited, Wrexham, Clwyd). Identical insulin doses were administered on both days by the same doctor group 1 and four in group 2. Mean blood glucose values (± SEM) were initially similar in the two groups (8-4±1-1 mmolIl and 9-6±1-4 mmol/l (151±20 mg/100 ml and 173±25 mg/100 ml) respectively) (NS). By 24 hours the mean blood glucose concentration had fallen in the group treated initially with the syringe but had risen in the group treated with the injector gun (6-0±0 8 mmol/l versus 13-3±2-1 mmol/l (108±14 mg/100 ml versus 239±38 mg/100 ml)) (p<0-01). After a further 24 hours, following the change in injection technique, mean blood glucose values had again risen with jet injection but fallen with syringe injection (8-7±3-2 mmol/l versus 9-8±2-0 mmol/l) (157±58 mg/100 ml versus 176±36 mg/100 ml)) (NS). On paired testing the change in blood glucose from the fasting value on each of the study days was significantly different between the two techniques before bedtime (n=9; p<0-01) and fasting the next day (n=9; p<005) (figure). 
The results clearly showed a rise in blood glucose values at 24 and 48 hours when using the injector gun but a corresponding fall when using the conventional syringe. Thus the effect of insulin given by jet injection was shorter lasting than an equivalent dose given by syringe.
Absorption may be faster-after jet injection owing to dispersion of the insulin, which may be a useful advantage of the technique. In this small study, however, the differences in blood glucose values between the two methods over the hours immediately after injection were not significantly different. The results emphasise that adjustment of insulin dosage will probably be necessary when altering the method of insulin administration. The advantage of less immediate pain with the injector gun was offset by more delayed pain and also more bleeding.
From the relatively few injections received the patients expressed no clear preference for this expensive new technique. This study provided no definite evidence to favour use of this particular injector gun over conventional syringe and needle. This conclusion may need to be revised when the results of studies of insulin absorption are available.
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